N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide

C74H108N6O11 — CID 172982090

IUPACN-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide
SMILESCC(=O)NCCOCCOCCNC(=O)CO/N=C1\CCC2C3CCc4cc(O)c(C56CC7CC(CC(C7)C5)C6)cc4C3CC[C@]12C.C[C@]12CCC3c4cc(C56CC7CC(CC(C7)C5)C6)c(O)cc4CCC3C1CC/C2=N\OCC(=O)NCCOCCOCCN
InChIInChI=1S/C38H55N3O6.C36H53N3O5/c1-24(42)39-9-11-45-13-14-46-12-10-40-36(44)23-47-41-35-6-5-32-30-4-3-28-18-34(43)33(19-31(28)29(30)7-8-37(32,35)2)38-20-25-15-26(21-38)17-27(16-25)22-38;1-35-7-6-27-28(30(35)4-5-33(35)39-44-22-34(41)38-9-11-43-13-12-42-10-8-37)3-2-26-17-32(40)31(18-29(26)27)36-19-23-14-24(20-36)16-25(15-23)21-36/h18-19,25-27,29-30,32,43H,3-17,20-23H2,1-2H3,(H,39,42)(H,40,44);17-18,23-25,27-28,30,40H,2-16,19-22,37H2,1H3,(H,38,41)/b41-35+;39-33+/t25?,26?,27?,29?,30?,32?,37-,38?;23?,24?,25?,27?,28?,30?,35-,36?/m00/s1
InChIKeyQRNNUZDLMIFCIS-LNKQYZFCSA-N
MW1257.71 g/mol
LogP10.57
Rot. Bonds25

About N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide

N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide (PubChem CID 172982090) has the molecular formula C74H108N6O11 and a molecular weight of 1257.71 g/mol. Its IUPAC name is N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide.

Molecular Properties

Compound NameN-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide
PubChem CID172982090
Molecular FormulaC74H108N6O11
Molecular Weight1257.71 g/mol
Exact Mass1256.81
IUPAC NameN-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide
SMILESCC(=O)NCCOCCOCCNC(=O)CO/N=C1\CCC2C3CCc4cc(O)c(C56CC7CC(CC(C7)C5)C6)cc4C3CC[C@]12C.C[C@]12CCC3c4cc(C56CC7CC(CC(C7)C5)C6)c(O)cc4CCC3C1CC/C2=N\OCC(=O)NCCOCCOCCN
InChIInChI=1S/C38H55N3O6.C36H53N3O5/c1-24(42)39-9-11-45-13-14-46-12-10-40-36(44)23-47-41-35-6-5-32-30-4-3-28-18-34(43)33(19-31(28)29(30)7-8-37(32,35)2)38-20-25-15-26(21-38)17-27(16-25)22-38;1-35-7-6-27-28(30(35)4-5-33(35)39-44-22-34(41)38-9-11-43-13-12-42-10-8-37)3-2-26-17-32(40)31(18-29(26)27)36-19-23-14-24(20-36)16-25(15-23)21-36/h18-19,25-27,29-30,32,43H,3-17,20-23H2,1-2H3,(H,39,42)(H,40,44);17-18,23-25,27-28,30,40H,2-16,19-22,37H2,1H3,(H,38,41)/b41-35+;39-33+/t25?,26?,27?,29?,30?,32?,37-,38?;23?,24?,25?,27?,28?,30?,35-,36?/m00/s1
InChIKeyQRNNUZDLMIFCIS-LNKQYZFCSA-N
XLogP10.57
TPSA233.88 Ų
H-Bond Donors6
H-Bond Acceptors14
Rotatable Bonds25
Heavy Atoms91
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001257.71
LogP ≤ 510.57
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide?
The IUPAC name of N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide (CID 172982090) is N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide.
What is the SMILES notation for N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide?
The canonical SMILES for N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide is CC(=O)NCCOCCOCCNC(=O)CO/N=C1\CCC2C3CCc4cc(O)c(C56CC7CC(CC(C7)C5)C6)cc4C3CC[C@]12C.C[C@]12CCC3c4cc(C56CC7CC(CC(C7)C5)C6)c(O)cc4CCC3C1CC/C2=N\OCC(=O)NCCOCCOCCN.
What is the InChIKey of N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide?
The InChIKey is QRNNUZDLMIFCIS-LNKQYZFCSA-N. The full InChI is InChI=1S/C38H55N3O6.C36H53N3O5/c1-24(42)39-9-11-45-13-14-46-12-10-40-36(44)23-47-41-35-6-5-32-30-4-3-28-18-34(43)33(19-31(28)29(30)7-8-37(32,35)2)38-20-25-15-26(21-38)17-27(16-25)22-38;1-35-7-6-27-28(30(35)4-5-33(35)39-44-22-34(41)38-9-11-43-13-12-42-10-8-37)3-2-26-17-32(40)31(18-29(26)27)36-19-23-14-24(20-36)16-25(15-23)21-36/h18-19,25-27,29-30,32,43H,3-17,20-23H2,1-2H3,(H,39,42)(H,40,44);17-18,23-25,27-28,30,40H,2-16,19-22,37H2,1H3,(H,38,41)/b41-35+;39-33+/t25?,26?,27?,29?,30?,32?,37-,38?;23?,24?,25?,27?,28?,30?,35-,36?/m00/s1.
What are the key properties of N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide?
N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide has a molecular weight of 1257.71 g/mol, XLogP of 10.57, 25 rotatable bonds, 6 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxyacetamide;2-[(E)-[(13S)-2-(1-adamantyl)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]amino]oxy-N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]acetamide is sourced from PubChem (CID 172982090), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).